Bengaluru, Aug. 11 -- Welcure Drugs & Pharmaceuticals Ltd today announced that its Board of Directors will meet on Friday, August 22, 2025 to consider the proposal of Stock Split and Bonus Issue. Following the company's stellar Q1FY26 financial results, this move is aimed at enhancing liquidity and broadening shareholding.

As per the proposal, the company has suggested Sub-division (Stock Split) of the company's equity shares in the ratio of 1:10 (i.e. one equity share into ten equity shares), subject to approvals as may be required. The company has also proposed issue of Bonus Shares up to 1:1 (i.e., one bonus equity share for every one equity share held), subject to availability of adequate reserves and receipt of requisite approvals....